本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

DICE Therapeutics, Inc.

47.55
0.0000
成交量:- -
成交额:2.07亿
市值:22.72亿
市盈率:-20.24
高:47.55
开:47.55
低:47.55
收:47.55
数据加载中...
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/21

重要事件披露

8-K - Current report
2022/02/17

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/11/12

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/09/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/09

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/08/27

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/08/27

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/25

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933